Post-operative radiotherapy in the management of metastatic inflammatory breast cancer

Post-operative radiotherapy in the management of metastatic inflammatory breast cancer

With this review, we aimed to describe the role of adjuvant radiotherapy in the therapeutic management of metastatic inflammatory breast cancer, a rare and aggressive disease historically characterized by high rates of recurrence and poor prognosis. In the context of a multimodality approach, Post-M...

Full description

Bibliographic Details
Main Authors: Marta Bottero, Alessandro Cancelli, Emanuele Alì, Elisabetta Ponti, Andrea Lancia, Riccardo Santoni, Gianluca Ingrosso
Format: Article
Language:English
Published: Turkiye Klinikleri 2019-04-01
Series:Journal of Oncological Sciences
Online Access:http://www.sciencedirect.com/science/article/pii/S2452336418300840
id doaj-9d93a53b98f741ca92a8b56fd97e93a1
record_format Article
spelling doaj-9d93a53b98f741ca92a8b56fd97e93a12020-11-25T00:06:20ZengTurkiye KlinikleriJournal of Oncological Sciences2452-33642019-04-01511922Post-operative radiotherapy in the management of metastatic inflammatory breast cancerMarta Bottero0Alessandro Cancelli1Emanuele Alì2Elisabetta Ponti3Andrea Lancia4Riccardo Santoni5Gianluca Ingrosso6Radiation Oncology, Tor Vergata University Hospital, Rome, ItalyRadiation Oncology, Tor Vergata University Hospital, Rome, ItalyRadiation Oncology, Tor Vergata University Hospital, Rome, ItalyRadiation Oncology, INI Città Bianca, ItalyRadiation Oncology, I.R.C.C.S San Matteo, Pavia, Italy; Corresponding author.Tor Vergata University Hospital, Viale Oxford 81, Italy.Radiation Oncology, Tor Vergata University Hospital, Rome, ItalyRadiation Oncology, Tor Vergata University Hospital, Rome, ItalyWith this review, we aimed to describe the role of adjuvant radiotherapy in the therapeutic management of metastatic inflammatory breast cancer, a rare and aggressive disease historically characterized by high rates of recurrence and poor prognosis. In the context of a multimodality approach, Post-Mastectomy Radiotherapy (PMRT) affirms its role as an appriopriate treatment strategy to improve loco-regional tumor control in selected patients. Further validation in prospective trials is required to better define a standardized therapeutic management of this disease.http://www.sciencedirect.com/science/article/pii/S2452336418300840
collection DOAJ
language English
format Article
sources DOAJ
author Marta Bottero
Alessandro Cancelli
Emanuele Alì
Elisabetta Ponti
Andrea Lancia
Riccardo Santoni
Gianluca Ingrosso
spellingShingle Marta Bottero
Alessandro Cancelli
Emanuele Alì
Elisabetta Ponti
Andrea Lancia
Riccardo Santoni
Gianluca Ingrosso
Post-operative radiotherapy in the management of metastatic inflammatory breast cancer
Journal of Oncological Sciences
author_facet Marta Bottero
Alessandro Cancelli
Emanuele Alì
Elisabetta Ponti
Andrea Lancia
Riccardo Santoni
Gianluca Ingrosso
author_sort Marta Bottero
title Post-operative radiotherapy in the management of metastatic inflammatory breast cancer
title_short Post-operative radiotherapy in the management of metastatic inflammatory breast cancer
title_full Post-operative radiotherapy in the management of metastatic inflammatory breast cancer
title_fullStr Post-operative radiotherapy in the management of metastatic inflammatory breast cancer
title_full_unstemmed Post-operative radiotherapy in the management of metastatic inflammatory breast cancer
title_sort post-operative radiotherapy in the management of metastatic inflammatory breast cancer
publisher Turkiye Klinikleri
series Journal of Oncological Sciences
issn 2452-3364
publishDate 2019-04-01
description With this review, we aimed to describe the role of adjuvant radiotherapy in the therapeutic management of metastatic inflammatory breast cancer, a rare and aggressive disease historically characterized by high rates of recurrence and poor prognosis. In the context of a multimodality approach, Post-Mastectomy Radiotherapy (PMRT) affirms its role as an appriopriate treatment strategy to improve loco-regional tumor control in selected patients. Further validation in prospective trials is required to better define a standardized therapeutic management of this disease.
url http://www.sciencedirect.com/science/article/pii/S2452336418300840
work_keys_str_mv AT martabottero postoperativeradiotherapyinthemanagementofmetastaticinflammatorybreastcancer
AT alessandrocancelli postoperativeradiotherapyinthemanagementofmetastaticinflammatorybreastcancer
AT emanueleali postoperativeradiotherapyinthemanagementofmetastaticinflammatorybreastcancer
AT elisabettaponti postoperativeradiotherapyinthemanagementofmetastaticinflammatorybreastcancer
AT andrealancia postoperativeradiotherapyinthemanagementofmetastaticinflammatorybreastcancer
AT riccardosantoni postoperativeradiotherapyinthemanagementofmetastaticinflammatorybreastcancer
AT gianlucaingrosso postoperativeradiotherapyinthemanagementofmetastaticinflammatorybreastcancer
_version_ 1725422614597337088

Similar Items